IHEvsGDOCETF Comparison
VS
iShares U.S. Pharmaceuticals ETF (IHE) belongs to the US Health Care segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. IHE's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, GDOC's top sector exposures are Healthcare. IHE is less expensive with a Total Expense Ratio (TER) of 0.37%, versus 0.75% for GDOC. IHE is up 21.86% year-to-date (YTD) with +$599M in YTD flows. GDOC performs worse with 3.01% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of IHE and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IHE vs GDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/08/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE GDOC | -1.15%-2.03% | +11.24%+8.64% | +21.86%+3.01% | +46.15%+11.32% | +71.07%+15.44% | +72.59%n/a |
| Flows | IHE GDOC | +$22M- | +$607M-$3M | +$599M-$2M | +$756M-$3M | +$848M-$86M | +$853M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE GDOC | +20.07%+15.49% | +18.27%+15.35% | +17.03%+14.97% | +16.59%n/a |
| Max drawdown | IHE GDOC | -5.03%-5.35% | -8.48%-15.39% | -16.04%-22.18% | -16.12%n/a |
| Max drawdown duration | IHE GDOC | 20d31d | 81d221d | 210d449d | 669dn/a |
Trading data
IHE | GDOC | |
Last sale 9/9/2026 at 1:30 PM | $102.19 | $36.69 |
| Previous close 09/09/2026 | $102.68 | $36.90 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GDOC
is actively managed and doesn’t replicate an indexIHE | GDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/9/2026 at 1:30 PM
Live
Closed
IHE | GDOC | |
|---|---|---|
| Last price | $102.19 | $36.69 |
| 1D performance | -0.48% | -0.55% |
| AuM | $1.64 B | $19.27 M |
| E/R | 0.37% | 0.75% |
Characteristics
IHE | GDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | Goldman Sachs |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | - |
| N° of holdings | 57 | 38 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | November 11, 2021 |
| ESG | No | No |
Exposure
Countries
IHE
USA
95.81%
Other
4.19%
GDOC
USA
79.52%
Other
20.48%
Sectors
IHE
Healthcare
99.62%
Other
0.38%
GDOC
Healthcare
97.92%
Other
2.08%
Advertisement
Diversification
IHE
Total weight of top 15 holdings out of 15
84.32%
GDOC
Total weight of top 15 holdings out of 15
71.18%
Top 15 holdings
Data as of July 31, 2026
IHE
Johnson & Johnson
21.85%
Eli Lilly & Co.
20.71%
Bristol Myers Squibb Co.
4.75%
Viatris, Inc.
4.56%
Merck & Co., Inc.
4.44%
Royalty Pharma Plc
4.41%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.81%
Jazz Pharmaceuticals Plc
3.58%
Elanco Animal Health, Inc.
2.92%
Corcept Therapeutics, Inc.
2.49%
Axsome Therapeutics, Inc.
2.24%
Crinetics Pharmaceuticals, Inc.
1.95%
Liquidia Corp.
1.35%
Ligand Pharmaceuticals, Inc.
1.31%
GDOC
Eli Lilly & Co.
13.11%
Johnson & Johnson
8.63%
Merck & Co., Inc.
6.83%
UnitedHealth Group, Inc.
6.44%
Guardant Health, Inc.
4.41%
argenx SE
3.71%
AstraZeneca PLC
3.59%
Edwards Lifesciences Corp.
3.30%
Thermo Fisher Scientific, Inc.
3.30%
Agilent Technologies, Inc.
3.28%
DexCom, Inc.
3.23%
Apogee Therapeutics, Inc.
3.00%
Intuitive Surgical, Inc.
2.88%
Lonza Group AG
2.79%
Cencora, Inc.
2.67%
Frequently asked questions about IHE and GDOC
How have the IHE and GDOC ETFs performed in 2026?
As of September 8, 2026, IHE is up 21.86% year-to-date (YTD), while GDOC has returned 3.01%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: IHE or GDOC?
Year-to-date, the IHE ETF saw +$599M in flows, compared to -$2M for GDOC.
Which ETF is more volatile: IHE or GDOC?
Over the past year, IHE had a volatility of 18.27%, while GDOC experienced 15.35%.
Which ETF is bigger: IHE or GDOC?
As of September 8, 2026, IHE holds $1.64 B in assets under management (AUM), while GDOC manages $19.27 M.
What sectors do the IHE and GDOC ETFs invest in?
IHE leans toward sectors like Healthcare. Meanwhile, GDOC focuses on Healthcare.
What are the top holdings of the IHE ETF and GDOC ETF?
IHE top holdings include Johnson & Johnson, Eli Lilly & Co. and Bristol Myers Squibb Co.. GDOC holds in its top three: Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc..
Which ETF is more diversified: IHE or GDOC?
IHE holds 57 securities with 84.32% of its assets in the top 15. GDOC has 38 securities and a top 15 weight of 71.18%.
Advertisement
Latest news about IHE & GDOC
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
